Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q1 FY22 results · Apr–Jun 2021
Procter & Gamble Health reported revenue from operations of ₹285.39 crore and net profit of ₹33.89 crore for Q1 FY22 (Apr–Jun 2021), on a standalone basis.
| Item | Q1 FY22 | Q1 FY21 | YoY | Q4 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 285.39 | — | — | 219.15 | +30.2% |
| Other income | 2.42 | — | — | 3.24 | −25.3% |
| Total income | 287.81 | — | — | 222.39 | +29.4% |
| Profit before tax | 43.53 | — | — | 26.10 | +66.8% |
| Net profit for the period | 33.89 | — | — | 15.77 | +114.9% |
| EPS, basic (₹) | 20.40 | — | — | 9.50 | +114.7% |
| Net margin (%) | 11.9 | — | 7.2 |
Standalone
- Filed with BSE
- 27 Aug 2021, 19:47 IST
- Board meeting
- 26 Aug 2021
- Period
- 01 Apr 2021 to 30 Jun 2021
- Review status
- Audited
- Source
- XBRL filing on BSE